Table 1 patient and treatment characteristics

number of patients

55

27

28

number of lesions

70

36

34

single/multiple lesions

40/15

18/9

22/6

gender (male/female)

35/20

19/8

16/12

age (median/range in years)

64/31–83

63/46–83

67/31–80

KPS (median/range in %)

90/60–100

90/60–100

95/70–100

histology (CRC/LC/BC/S/O)

–

–

10/4/4/2/9

Child-Pugh stage (A/B/C)

–

21/5/1

–

fiducials (n/%)

42/76

18/67

24/86

abdominal compression (n/%)

26/47

14/52

12/43

GTV per patient (median/range in ccm)

14.6/0.4–204

15.5/1.2–204

13.25/0.4–98.2

GTV per lesion (median/range in ccm)

6.6/0.2–204

7.5/0.9–204

6.2/0.2–98.2

PTV per patient (median/range in ccm)

75.5/17.7–511.6

92.7/17.7–511.6

61.1/19.3–314

PTV per lesion (median/range in ccm)

59/15–512

61/15–512

51/15–314

dose concept (3 × 12.5/5 × 8/other)

28/11/16

16/6/5

12/5/9

BED max (median/range)

168.1/60.3–190

168.2/60.3–168.2

118/80.4–190

actual treatment (SBRT/TACE+SBRT)

–

12/15

–